Open-label non-blinded cohort study on anti-histaminic resistant chronic idiopathic urticaria in Western India
Introduction: Chronic idiopathic urticaria (CIU) is a chronic relapsing disease with hives for a period of six weeks or more. It has a significant impact on the physical and mental well-being of patients. Aims and Objectives: Open-label non-blinded study of over 600 patients diagnosed with CIU was d...
Saved in:
Main Authors: | Subramanian Natarajan (Author), Poonam Subramanian (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Updosing of nonsedating anti-histamines in recalcitrant chronic urticaria
by: Kiran Godse, et al.
Published: (2016) -
Systematic review of excess mortality in India during the Covid-19 pandemic with differentiation between model-based and data-based mortality estimates
by: Subramanian Natarajan, et al.
Published: (2022) -
An Open-Label, Investigator-Initiated, Single-Centre Pilot Study to Determine the Safety and Efficacy of Tofacitinib in Resistant Chronic Spontaneous Urticaria
by: Abhishek De, et al.
Published: (2024) -
Olopatadine in chronic idiopathic urticaria
by: Godse Kiran
Published: (2009) -
Pediatric Miller Fisher syndrome mimicking anti-histaminic drug toxicity
by: Gowsinivedha Natarajan, et al.
Published: (2023)